Method of identifying a MHC class I restricted T cell response
US7892828B2 · kind B2 · utility
1Cited by
5References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 13, 2009 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Oct 13, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are peptides and polypeptides derived from the MUC-1 polypeptide which are able to activate Cytotoxic T Lymphocyte (CTL) response, analogues of such peptides and polypeptides nucleotide sequences encoding such peptides and polypeptides and therapeutic uses thereof. Moreover, indications for selecting appropriate minimal antigenic MUC-1 polypeptides with reference to the HLA-type of the patient to be treated or tested are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.